Top compounds associated with response to RNF112


Feature Type Standardized
Nominal ANOVA
mRNA PX-12 CTRPv2 pan-cancer AAC 0.087 0.009
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.01
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.12 0.01
mRNA AS605240 GDSC1000 pan-cancer AAC -0.09 0.01
mRNA indisulam CTRPv2 pan-cancer AAC 0.097 0.01
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA JW-74 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.19 0.02
Download CSV